fbpx Skip to main content

Member's Profile

Therini Bio

681 Gateway Blvd Ste 411
South San Francisco,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2020
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Therini Bio
Biotech Company
Therini Bio, Inc. is a vascular biology company focused on developing novel therapies based on a deep understanding of fibrin and its role in driving pathological inflammatory processes initiated by loss of vascular integrity. Our initial focus is on inflammation in neurodegenerative diseases, but the mechanism is implicated in a variety of peripheral indications.

The Company was founded upon the pioneering work of Katerina Akassoglou, Ph.D., Senior Investigator at Gladstone Institutes and Professor of Neurology at the University of California, San Francisco. Dr. Akassoglou and colleagues discovered that fibrin, a blood-clotting factor, is implicated in the toxic inflammation that activates the brain’s immune cell response and damages neurons resulting in loss of brain function in models for Alzheimer’s disease and multiple sclerosis.
Related News
No related news posted by this Member